BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26947789)

  • 1. Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients.
    Scopinaro N; Camerini G; Papadia F; Andraghetti G; Cordera R; Adami GF
    Surg Obes Relat Dis; 2016 May; 12(4):822-827. PubMed ID: 26947789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of high-frequency glucose-entrained insulin oscillations in obese subjects with type 2 diabetes after biliopancreatic diversion.
    Leonardou AS; Karystianos C; Argyropoulos C; Nikiforidis GC; Kalfarentzos F; Alexandrides TK
    Surg Obes Relat Dis; 2016; 12(8):1539-1547. PubMed ID: 27425836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion.
    Adami GF; Camerini G; Papadia F; Catalano MF; Carlini F; Cordera R; Scopinaro N
    Obes Surg; 2019 Jan; 29(1):239-245. PubMed ID: 30232725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms.
    Astiarraga B; Gastaldelli A; Muscelli E; Baldi S; Camastra S; Mari A; Papadia F; Camerini G; Adami G; Scopinaro N; Ferrannini E
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2765-73. PubMed ID: 23666972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes.
    Camerini GB; Papadia FS; Carlini F; Catalano M; Adami GF; Scopinaro N
    Surg Obes Relat Dis; 2016 Feb; 12(2):345-9. PubMed ID: 26381876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion.
    Briatore L; Salani B; Andraghetti G; Danovaro C; Sferrazzo E; Scopinaro N; Adami GF; Maggi D; Cordera R
    Obesity (Silver Spring); 2008 Jan; 16(1):77-81. PubMed ID: 18223616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function.
    Vasques AC; Pareja JC; da Saúde de Oliveira M; Novaes FS; Lima MM; Chaim ÉA; Piccinini F; Dalla Man C; Cobelli C; Geloneze B
    Obes Surg; 2016 Nov; 26(11):2572-2580. PubMed ID: 27091049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35.
    Scopinaro N; Adami GF; Papadia FS; Camerini G; Carlini F; Fried M; Briatore L; D'Alessandro G; Andraghetti G; Cordera R
    Ann Surg; 2011 Apr; 253(4):699-703. PubMed ID: 21475009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment.
    Del Genio G; Gagner M; Limongelli P; Tolone S; Pournaras D; le Roux CW; Brusciano L; Licia Mozzillo A; Del Genio F; Docimo L
    Surg Obes Relat Dis; 2016 May; 12(4):815-821. PubMed ID: 27150339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
    Lee WJ; Chong K; Chen CY; Chen SC; Lee YC; Ser KH; Chuang LM
    Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB.
    Frenken M; Cho EY
    Obes Facts; 2011; 4 Suppl 1(Suppl 1):13-7. PubMed ID: 22027284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding.
    Alam I; Stephens JW; Fielding A; Lewis KE; Lewis MJ; Baxter JN
    Surg Obes Relat Dis; 2012; 8(6):752-63. PubMed ID: 22177976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Resolution at 10 Years After Biliopancreatic Diversion in Overweight and Class 1 Obese Patients with Type 2 Diabetes.
    Papadia FS; Carlini F; Rubartelli A; Battistini M; Cordera R; Adami GF; Camerini G
    Obes Surg; 2022 Mar; 32(3):845-851. PubMed ID: 35013895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study.
    Scopinaro N; Adami GF; Papadia FS; Camerini G; Carlini F; Briatore L; D'Alessandro G; Parodi C; Weiss A; Andraghetti G; Catalano M; Cordera R
    Obes Surg; 2011 Jul; 21(7):880-8. PubMed ID: 21541815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion.
    Scopinaro N; Adami GF; Bruzzi P; Cordera R
    Obes Surg; 2017 Jul; 27(7):1705-1708. PubMed ID: 28101844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial Triglyceride, Glucose and Insulin Levels 10 Years After Bariatric Surgery in Women With Severe Obesity - A Pilot Study: Part 2 - Biliopancreatic Diversion.
    Metelcová T; Hainer V; Hill M; Kalousková P; Vrbíková J; Šrámková P; Fried M; Taxová Braunerová R; Kunešová M
    Physiol Res; 2023 Dec; 72(S4):S405-S410. PubMed ID: 38116774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study.
    Tsoli M; Chronaiou A; Kehagias I; Kalfarentzos F; Alexandrides TK
    Surg Obes Relat Dis; 2013; 9(5):667-77. PubMed ID: 23466015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Cell function improvements in grade I/II obese subjects with type 2 diabetes 1 month after biliopancreatic diversion: results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies.
    Junqueira Vasques AC; Pareja JC; de Oliveira Mda S; Satake Novaes F; Miranda de Oliveira Lima M; Chaim ÉA; Piccinini F; Dalla Man C; Cobelli C; Geloneze B
    Diabetes Care; 2013 Dec; 36(12):4117-24. PubMed ID: 24135388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should metabolic surgery be offered in morbidly obese patients with type I diabetes?
    Robert M; Belanger P; Hould FS; Marceau S; Tchernof A; Biertho L
    Surg Obes Relat Dis; 2015; 11(4):798-805. PubMed ID: 25868828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity.
    Briatore L; Salani B; Andraghetti G; Maggi D; Adami GF; Scopinaro N; Cordera R
    Obesity (Silver Spring); 2010 May; 18(5):932-6. PubMed ID: 20186136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.